FDA Advisers Recommend Authorization of Pfizer/BioNTech Coronavirus Vaccine

The US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee voted Thursday to recommend the agency grant emergency use authorization.

Posted: Dec 10, 2020 6:22 PM
Updated: Dec 10, 2020 6:24 PM

The US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee voted Thursday to recommend the agency grant emergency use authorization to Pfizer and BioNTech's coronavirus vaccine.

Seventeen members voted yes, four voted no and one abstained.

This vote doesn't mean the vaccine will be authorized immediately.

The FDA will now decide whether to accept the recommendation but has signaled that it will issue the EUA for the vaccine.

Then, the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices must meet to decide whether it recommends that the vaccine be deployed for use. ACIP has a meeting scheduled for Friday, and expects to vote during another meeting, scheduled for Sunday.

Operation Warp Speed officials say they will start shipping the vaccine within 24 hours of FDA authorization.

The VRPBAC is also scheduled to meet again next week to discuss Moderna's EUA application.

Evansville
Cloudy
36° wxIcon
Hi: 39° Lo: 32°
Feels Like: 28°
Owensboro
Cloudy
36° wxIcon
Hi: 40° Lo: 32°
Feels Like: 29°
Mount Carmel
Cloudy
34° wxIcon
Hi: 37° Lo: 30°
Feels Like: 26°
Madisonville
Cloudy
37° wxIcon
Hi: 40° Lo: 33°
Feels Like: 33°
Washington
Cloudy
33° wxIcon
Hi: 36° Lo: 30°
Feels Like: 26°
Temperatures fall and snow chances return to the Tri-State.
WEVV 4K Doppler Radar
WEVV 7-Day Forecast
WEVV Watches & Warnings

Community Events